The Russian biopharmaceutical company Promomed announced a launch of another semaglutide-based obesity drug, Velgia Eco. It will be sold in disposable injectors. A new...
From January to April 2025, 17.1 million packages of topical wound healing drugs worth 5.1 billion rubles (in retail prices, including VAT) were sold...
Russian President Vladimir Putin has signed a law clarifying the state regulation of the dietary supplements market. The Government of the Russian Federation has...
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
